StockWatch
·
Pharmaceuticals
AGM/EGM24 Sept 2026, 09:56 pm

Wanbury Ltd: Mohan Kumar Rayana Re-appointed Whole-time Director

AI Summary

Wanbury Ltd announced at its 38th Annual General Meeting held on September 24, 2026, the re-appointment of Mr. Mohan Kumar Rayana as Whole-time Director. His tenure will continue beyond the age of 70, from August 21, 2026, up to August 20, 2031. The AGM also approved the appointment and remuneration of M/s. ABK & Associates as the company's Cost Auditor for the Financial Year 2026-2027. Mr. Rayana brings over 25 years of advisory experience in business and management, with a focus on strategy, talent enrichment, and acquisitions within the pharmaceutical sector.

Key Highlights

  • Mohan Kumar Rayana re-appointed as Whole-time Director until August 2031.
  • Re-appointment continues beyond the age of 70.
  • ABK & Associates appointed as Cost Auditor for FY 2026-2027.
  • AGM approved both appointments and associated remuneration.
  • Mr. Rayana has extensive experience in pharma business strategy.